ArticleJournal for immunotherapy of cancer2021

G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.

Paula Martinez Sanz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.